These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20348143)

  • 21. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.
    Hohnloser SH; Basic E; Nabauer M
    Clin Res Cardiol; 2019 Sep; 108(9):1042-1052. PubMed ID: 30771066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing rate of atrial fibrillation from 2003 to 2011 in patients with ischaemic stroke: results from 55,551 patients in a nationwide registry.
    Jespersen SF; Christensen LM; Christensen A; Christensen H
    Eur J Neurol; 2015 May; 22(5):839-44. PubMed ID: 25683654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adequacy of anticoagulant prevention in patients with atrial fibrillation].
    García-García J; Calleja-Puerta S; de la Vega-Cerezales V; Benavente-Fernández L; Rodríguez-Rodríguez S; Hernández-Lahoz C
    Rev Neurol; 2005 Oct 1-15; 41(7):399-403. PubMed ID: 16193445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation characteristics in patients with ischaemic stroke.
    Staszewski J
    Kardiol Pol; 2007 Jul; 65(7):751-7; discussion 758-9. PubMed ID: 17694456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
    García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM
    Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.
    Deplanque D; Leys D; Parnetti L; Schmidt R; Ferro J; de Reuck J; Mas JL; Gallai V;
    Cerebrovasc Dis; 2006; 21(5-6):372-9. PubMed ID: 16490950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
    Wong CX; Lee SW; Gan SW; Mahajan R; Rangnekar G; Pathak RK; Twomey D; Schultz C; Ganesan AN; Brooks AG; Roberts-Thomson KC; Brown A; Lau DH; Sanders P
    Int J Cardiol; 2015 Jul; 191():20-4. PubMed ID: 25965590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke.
    Sanoski CA
    J Pharm Pract; 2013 Jun; 26(3):204-13. PubMed ID: 22842506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of atrial fibrillation after stroke and the risk of recurrent stroke.
    Kamel H; Johnson DR; Hegde M; Go AS; Sidney S; Sorel M; Hills NK; Johnston SC
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):726-31. PubMed ID: 21546265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.
    Piccini JP; Xu H; Cox M; Matsouaka RA; Fonarow GC; Butler J; Curtis AB; Desai N; Fang M; McCabe PJ; Page Ii RL; Turakhia M; Russo AM; Knight BP; Sidhu M; Hurwitz JL; Ellenbogen KA; Lewis WR;
    Circulation; 2019 Mar; 139(12):1497-1506. PubMed ID: 30700141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
    Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
    Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.
    Engdahl J; Holmén A; Rosenqvist M; Strömberg U
    Europace; 2018 Nov; 20(FI_3):f306-f311. PubMed ID: 29688312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.
    Li X; Tse VC; Au-Doung LW; Wong ICK; Chan EW
    Europace; 2017 Jun; 19(6):937-947. PubMed ID: 27209573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
    Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
    J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.